During the past decade, Investigators Research Group, LLC conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 19 clinical trials were completed, i.e. on average, 135.7% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 10 clinical trials were completed. i.e. 166.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Investigators Research Group, LLC" #1 sponsor was "Pfizer" with 6 trials, followed by "Urovant Sciences GmbH" with 3 trials sponsored, "AstraZeneca" with 2 trials sponsored, "Bayer" with 2 trials sponsored and "BioCryst Pharmaceuticals" with 2 trials sponsored. Other sponsors include 8 different institutions and companies that sponsored additional 16 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Investigators Research Group, LLC" #1 collaborator was "Eli Lilly and Company" with 3 trials as a collaborator, "BioCrossroads" with 2 trials as a collaborator, "Bristol-Myers Squibb" with 2 trials as a collaborator, "Indiana University School of Medicine" with 2 trials as a collaborator and "Regenstrief Institute, Inc." with 2 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Investigators Research Group, LLC" are "Hot Flashes" (3 trials), "Cardiovascular Disease" (2 trials), "Diabetes Mellitus, Type 2" (2 trials), "Overactive Bladder" (2 trials) and "Type 2 Diabetes" (2 trials). Many other conditions were trialed in "Investigators Research Group, LLC" in a lesser frequency.

Most popular intervention types in "Investigators Research Group, LLC" are "Drug" (22 trials), "Other" (4 trials), "Biological" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (15 trials), "Dapagliflozin" (2 trials), "Elinzanetant (BAY3427080)" (2 trials), "Peramivir" (2 trials) and "Tolterodine Tartrate ER" (2 trials). Other intervention names were less common.

The vast majority of trials in "Investigators Research Group, LLC" are 24 trials for "All" genders and 4 trials for "Female" genders.

Currently, there are NaN active trials in "Investigators Research Group, LLC". undefined are not yet recruiting, undefined are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 18 completed trials in Investigators Research Group, LLC, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Investigators Research Group, LLC, 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 19 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".